ArticleCells2020

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.

Dusana Majera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.